Thompson Siegel & Walmsley LLC Purchases 304,427 Shares of Bath & Body Works, Inc. $BBWI

Thompson Siegel & Walmsley LLC boosted its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 151.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 505,177 shares of the company’s stock after acquiring an additional 304,427 shares during the period. Thompson Siegel & Walmsley LLC’s holdings in Bath & Body Works were worth $10,144,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Diamond Hill Capital Management Inc. grew its stake in shares of Bath & Body Works by 29.9% in the 3rd quarter. Diamond Hill Capital Management Inc. now owns 369,452 shares of the company’s stock valued at $9,517,000 after purchasing an additional 85,000 shares during the period. Allianz Asset Management GmbH boosted its holdings in shares of Bath & Body Works by 58.8% in the 3rd quarter. Allianz Asset Management GmbH now owns 263,628 shares of the company’s stock worth $6,791,000 after acquiring an additional 97,640 shares in the last quarter. SG Americas Securities LLC boosted its holdings in shares of Bath & Body Works by 725.3% in the 4th quarter. SG Americas Securities LLC now owns 466,338 shares of the company’s stock worth $9,364,000 after acquiring an additional 409,831 shares in the last quarter. Chase Investment Counsel Corp acquired a new position in Bath & Body Works during the 4th quarter worth $1,606,000. Finally, Jupiter Asset Management Ltd. lifted its holdings in Bath & Body Works by 553.2% during the 3rd quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock worth $95,685,000 after buying an additional 3,145,797 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have recently weighed in on BBWI. Telsey Advisory Group cut their price target on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a research note on Thursday, May 28th. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. The Goldman Sachs Group cut their price target on Bath & Body Works from $26.00 to $23.00 and set a “neutral” rating on the stock in a research note on Thursday, May 28th. Piper Sandler began coverage on Bath & Body Works in a research note on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target on the stock. Finally, Citigroup downgraded Bath & Body Works from a “buy” rating to a “neutral” rating and increased their price target for the company from $21.00 to $25.00 in a research note on Tuesday, February 17th. Three research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company. According to MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and an average target price of $21.93.

Bath & Body Works Stock Down 6.8%

NYSE:BBWI opened at $18.66 on Tuesday. The firm has a market capitalization of $3.76 billion, a price-to-earnings ratio of 5.24, a price-to-earnings-growth ratio of 2.00 and a beta of 1.42. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $33.96. The stock’s 50 day moving average price is $18.62 and its two-hundred day moving average price is $20.18.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same quarter in the previous year, the firm earned $0.49 EPS. The business’s quarterly revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, analysts anticipate that Bath & Body Works, Inc. will post 2.6 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date is Friday, June 5th. Bath & Body Works’s payout ratio is presently 22.47%.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.